CHM 11.1% 1.0¢ chimeric therapeutics limited

litigation and loan finance disclosure

  1. 1,405 Posts.
    lightbulb Created with Sketch. 4
    CHM's biggest asset is its mmx litigation. what i would like to know is the details of the litigation finance contract. If for example chm has to give the litigation financier say 50% of the proceeds of a win then the shareholders and the general public should know because it will make a substantial difference to any decision to buy or sell chm.

    Further chm has entered into various loan agreements and the details of those have not been disclosed.

    Come on ASX make this mob disclose the market sensitive information.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.001(11.1%)
Mkt cap ! $12.51M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $59.29K 5.966M

Buyers (Bids)

No. Vol. Price($)
3 2110077 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1054546 2
Last trade - 16.10pm 03/12/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.